<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
OPHTHALMIC IMAGING SYSTEMS
[Name of Issuer]
COMMON STOCK, NO PAR VALUE
[Title of Class of Securities]
683737
(CUSIP Number)
Arthur Silber
5508 Randall Road,
Montreal, Quebec H4V 2V8, Canada
(514) 847-6341
with a copy to:
B. J. Yankowitz
Heenan Blaikie
9401 Wilshire Boulevard, Suite 1100
Beverly Hills, CA 90212
(310) 275-3600
(Name, address and telephone number of person
authorized to receive notices and communications)
Not applicable
(Date of event which requires filing of this statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-(b)(3) or (4), check the following box: [___]
Note: Six copies of this statement, including all exhibits, should be fiiled
with the Commission. See Rule 13d-1(a) for other parties to whom copies are to
be sent.
- ----------------------------
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment contianing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
(Continued on following pages.)
<PAGE>
CUSIP No. 683737 Page 2 of 5 Pages
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
Arthur Silber
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [__]
(b) [ x ]
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS*
PF
- --------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [___]
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Canada
- --------------------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF
31,500
SHARES --------------------------------------------------------
8. SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
--------------------------------------------------------
EACH 9. SOLE DISPOSITIVE POWER
REPORTING 31,500
PERSON --------------------------------------------------------
10. SHARED DISPOSITIVE POWER
WITH
0
- --------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
31,500
- --------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
N/A [___]
- --------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.8% BASED ON 4,155,428 SHARES OF COMMON STOCK REPORTED AS
OUTSTANDING AS OF APRIL 14, 1999
- --------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSONS*
IN
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 683737 Page 3 of 5 Pages
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
Victoria Dadouche
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [__]
(b) [ x ]
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS*
PF
- --------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [___]
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
Canada
- --------------------------------------------------------------------------------
7. SOLE VOTING POWER
NUMBER OF
191,500
SHARES --------------------------------------------------------
8. SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
--------------------------------------------------------
EACH 9. SOLE DISPOSITIVE POWER
REPORTING 191,500
PERSON --------------------------------------------------------
10. SHARED DISPOSITIVE POWER
WITH
0
- --------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
31,500
- --------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
N/A [___]
- --------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.6% BASED ON 4,155,428 SHARES OF COMMON STOCK REPORTED AS
OUTSTANDING AS OF APRIL 14, 1999
- --------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSONS*
IN
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 683737 Page 4 of 5 Pages
Item 1. Security and Issuer.
This Schedule 13D relates to the shares of Common Stock, no par value
("Common Stock") of Ophthalmic Imaging Systems (the "Company"). The address of
the principal executive offices of the Company is 221 Lathrop Way, Suite 1,
Sacramento California 95815.
Item 2. Identity And Background.
(a) This Schedule 13D is being filed by Arthur Silber and Victoria
Dadouche, who are husband and wife. Each of Arthur Silber and Victoria Dadouche
disclaim beneficial ownership of the shares of Common Stock owned by the other.
Neither owns beneficially more than 5 percent of the outstanding Common Stock;
nevertheless, in an abundance of caution, Mr. Silber and Ms. Dadouche are
voluntarily making this filing.
(b) The address of the filing persons is 5508 Randall Road, Cote St.
Luc, Quebec H4V 2V8, Canada.
(c) Mr. Silber is Vice-President of Wood Gundy Private Client
Investments, a division of CIBC World Markets Inc., 600 de Maisonneuve Boulevard
W., Suite 3050, Montreal, Quebec H3A 3J2, Canada. Ms. Dadouch is not presently
employed.
(d) Not Applicable.
(e) Not Applicable.
(f) Mr. Silber and Ms. Dadouche are both citizens of Canada.
Item 3. Source and Amount of Funds or Other Consideration.
The source of funds used to make the purchases was personal funds of Mr.
Silber and Ms. Dadouche.
Item 4. Purpose of Transaction.
The filing persons have purchased their Common Stock of the Company for
investment purposes. Originally, such purchases were made in reliance on the
merger agreement between the Company and Premiere Laser Systems, Inc.
("PREMIERE"). As described in the Company's filings, the agreement was never
consummated. According to Amendment No. 13 to its Schedule 13D, Premiere has
made a proposal to acquire by merger of all of the outstanding shares of common
stock of the Company that it does not already own in exchange for shares of
Premiere's Common Stock. The filing persons have indicated to the Company that
they would oppose such a transaction. The filing persons reserve the right to
vote against the proposed merger, as well as any rights they may have as
dissenting shareholders under Sections 1300 ET SEQ. of the California
Corporations Code. While the filing persons at this time have no intention of
seeking membership on the Company's Board of Directors or proposing an
alternative transaction, they reserve the right to do so in the future.
<PAGE>
CUSIP No. 683737 Page 5 of 5 Pages
Ms. Dadouche acquired her 191,500 shares of Common Stock from Mr. Silber,
and may in the future sell them back to Mr. Silber.
Each of Mr. Silber and Ms. Dadouche own sole voting power and sole
dispositive power over their respective shares.
Item 5. Interest in Securities of the Issuer.
Mr. Silber owns 31,500 shares of Common Stock, represending 0.8 % of the
outstanding shares (based on 4,155,428 shares of Common Stock outstanding, as of
April 14, 1999, as set forth in the Company's Form 10-QSB for the fiscal quarter
ending February 28, 1999). Ms. Dadouch owns 191,500 shares, representing 4.6 %
of the outstanding shares of Common Stock.
Item 6. Contracts, Arrangements, Understandings or Relationships with
Respect to Securities of the Issuer.
Not Applicable.
Item 7. Material to be filed as Exhibits.
Not Applicable.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complte and
correct.
Dated: June 28, 1999 /s/ Arthur Silber
--------------------------------------------
Arthur Silber
/s/ Victoria Dadouche
--------------------------------------------
Victoria Dadouche
